The company has entered into an agreement with Visiox Pharma LLC (Visiox) to grant exclusive worldwide rights (except for India and Greater China) for the development and commercialisation of PDP-716 and SDN-037, SPARC said in a statement.from Moneycontrol Business News https://ift.tt/3IumBz4
No comments:
Post a Comment